Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.37M 2.13M 1.99M 1.8M 3.38M 225M 3.4M 23.84M 9.31M 117M 8.89M 8.7M 376M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.37M 3.03M 2.83M 2.56M 4.81M 321M 4.84M 33.91M 13.24M 166M 12.64M 12.37M 535M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
15/07 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
17/04 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
20/02 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/10/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
07/10/25 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/09/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/09/25 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/04/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/01/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
07/01/25 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/12/24 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/11/24 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
26/11/24 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week+42.86%
1 month+100.00%
6 months-55.56%
Current year-60.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+42.86%-50.00%-50.00% 2.44M
-2.01%-7.86%+54.60%+70.97% 70.44B
+3.84%-11.02%+8.59%+58.77% 50.31B
+3.35%+1.42%+11.85%+37.39% 47.51B
+0.55%+1.41%+27.84%+31.55% 42.91B
+2.82%-3.82%+306.73%+466.22% 40.39B
+0.64%-3.35%+9.62%+102.26% 39.69B
+0.06%-1.43%+10.47%+43.27% 30.59B
-2.95%-14.09%+37.94%+1.30% 26.8B
-0.44%-6.71%-13.40%-8.36% 22.36B
Average +0.58%-5.02%+40.42%+75.34% 37.1B
Weighted average by Cap. +0.76%-5.44%+53.48%+94.73%

Financials

2024 2025
Net sales 249K 224K 209K 189K 355K 23.68M 357K 2.51M 978K 12.29M 934K 914K 39.53M 303K 272K 254K 230K 433K 28.84M 435K 3.05M 1.19M 14.97M 1.14M 1.11M 48.14M
Net income -651K -586K -547K -495K -930K -61.98M -936K -6.56M -2.56M -32.17M -2.45M -2.39M -103M -549K -493K -460K -417K -784K -52.23M -788K -5.53M -2.16M -27.11M -2.06M -2.02M -87.18M
Net Debt 939K 845K 788K 714K 1.34M 89.39M 1.35M 9.46M 3.69M 46.39M 3.53M 3.45M 149M 1M 899K 839K 761K 1.43M 95.2M 1.44M 10.07M 3.93M 49.41M 3.76M 3.67M 159M
Projected Income Statement - Annual - Cannabis Bioscience International Holdings, Inc.
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
15/10/26 USD 0.000200 0.00% 700,100
13/10/26 USD 0.000200 0.00% 190,150
12/10/26 USD 0.000200 +25.00% 130,100
09/10/26 USD 0.000160 -20.00% 50,050
08/10/26 USD 0.000200 +42.86% 566,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock